Audit 322154

FY End
2023-12-31
Total Expended
$298.09M
Findings
0
Programs
10
Organization: Kaleida Health (NY)
Year: 2023 Accepted: 2024-09-30
Auditor: Kpmg LLP

Organization Exclusion Status:

Checking exclusion status...

Contacts

Name Title Type
DR8QNDMDL5J3 Nicholas Southard Auditee
7167137014 Martin Dunbar Auditor
No contacts on file

Notes to SEFA

Title: 3 (a) Loans Outstanding (ALN 14.128) Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (Schedule) presents the activity of federal award programs administered by Kaleida is in accordance with the requirements of Title 2 U.S. Code of Federal Regulation: Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a select portion of the operations of the Kaleida, it is not intended to and does not present the financial position, changes in net assets, or cash flows of Kaleida. The Schedule is presented on the accrual basis of accounting, except Provide Relief Funds (note 3(e)). The amounts reported as federal expenditures were obtained from Kaleida’s general ledger which is the source of Kaleida’s consolidated financial statements. The general ledger is reconciled to the appropriate federal financial reports for the applicable program and periods. The amounts reported in these federal financial reports are prepared from records maintained for each program. De Minimis Rate Used: N Rate Explanation: Kaleida Health has elected not to charge the 10% de minimis indirect cost rate. Kaleida has the following obligations outstanding that are insured or coinsured by the U.S. Department of Housing and Urban Development, with a summary of loan activity in 2023. Loan Loan balance at balance at Original December 31, December 31, Contract number ALN loan amount 2022 Payments Borrowings 2023 014-13007 14.128 $ 189,588,800 4,332,584 4,332,584 — — 014-10039 14.128 57,540,000 33,057,807 2,693,495 — 30,364,312 014-10039 14.128 18,290,000 9,173,066 847,298 — 8,325,768 014-10047 14.128 100,253,000 68,761,089 3,619,166 — 65,141,923 014-10050 14.128 51,864,100 37,803,910 2,080,724 — 35,723,186 014-10065 14.128 128,042,400 111,273,763 3,683,742 — 107,590,021 $ 545,578,300 264,402,219 17,257,009 — 247,145,210 Loan balances outstanding at the beginning of the year plus current year borrowings are included in the federal expenditures presented in the Schedule.
Title: 3 (b) Maternal and Child Health Services Block Grant (ALN 93.994 & 93.217) Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (Schedule) presents the activity of federal award programs administered by Kaleida is in accordance with the requirements of Title 2 U.S. Code of Federal Regulation: Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a select portion of the operations of the Kaleida, it is not intended to and does not present the financial position, changes in net assets, or cash flows of Kaleida. The Schedule is presented on the accrual basis of accounting, except Provide Relief Funds (note 3(e)). The amounts reported as federal expenditures were obtained from Kaleida’s general ledger which is the source of Kaleida’s consolidated financial statements. The general ledger is reconciled to the appropriate federal financial reports for the applicable program and periods. The amounts reported in these federal financial reports are prepared from records maintained for each program. De Minimis Rate Used: N Rate Explanation: Kaleida Health has elected not to charge the 10% de minimis indirect cost rate. Kaleida operates numerous programs designed to provide health services to pregnant women, mothers, infants, and children. Funding is provided from federal and various other sources. The federal portion of the award under these programs for the year ended December 31, 2023, is as follows: Contract ALN Total Federal Federal number number Grant expenditures share expenditures C36786GG 93.994 Regional Perinatal Center Grant $ 323,569 4.63 % $ 14,981 C36276GG 93.217 Regional Perinatal Center Grant 323,569 17.64 % 57,078 C32397GG 93.994 School Based Health Program-Core Grant 195,905 17.30 % 33,892 C37178GG 93.994 School Based Health Program-Core Grant 113,559 17.30 % 19,646 $ 956,602 $ 125,597
Title: 3 (c) National Bioterrorism Hospital Preparedness Program (ALN 93.889) Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (Schedule) presents the activity of federal award programs administered by Kaleida is in accordance with the requirements of Title 2 U.S. Code of Federal Regulation: Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a select portion of the operations of the Kaleida, it is not intended to and does not present the financial position, changes in net assets, or cash flows of Kaleida. The Schedule is presented on the accrual basis of accounting, except Provide Relief Funds (note 3(e)). The amounts reported as federal expenditures were obtained from Kaleida’s general ledger which is the source of Kaleida’s consolidated financial statements. The general ledger is reconciled to the appropriate federal financial reports for the applicable program and periods. The amounts reported in these federal financial reports are prepared from records maintained for each program. De Minimis Rate Used: N Rate Explanation: Kaleida Health has elected not to charge the 10% de minimis indirect cost rate. Kaleida has received a federally funded grant from Healthcare Association of New York State (HRSA) to initiate a bioterrorism hospital preparedness program. Awards under this program for the year ended December 31, 2023 are as follows: Contract Total Federal Federal number Program expenditures share expenditures 15-1000-04 HRSA Bioterrorism $ 82,677 100 % $ 82,677 15-1000-05 HRSA Bioterrorism 21,014 100 % 21,014 $ 103,691 $ 103,691
Title: 3 (d)   Provider Relief Funds – (ALN 93.498) Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (Schedule) presents the activity of federal award programs administered by Kaleida is in accordance with the requirements of Title 2 U.S. Code of Federal Regulation: Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a select portion of the operations of the Kaleida, it is not intended to and does not present the financial position, changes in net assets, or cash flows of Kaleida. The Schedule is presented on the accrual basis of accounting, except Provide Relief Funds (note 3(e)). The amounts reported as federal expenditures were obtained from Kaleida’s general ledger which is the source of Kaleida’s consolidated financial statements. The general ledger is reconciled to the appropriate federal financial reports for the applicable program and periods. The amounts reported in these federal financial reports are prepared from records maintained for each program. De Minimis Rate Used: N Rate Explanation: Kaleida Health has elected not to charge the 10% de minimis indirect cost rate. Kaleida has received provider relief funds from Health Resources and Services Administration to support relief of related expenses or lost revenues attributable to COVID-19. The Schedule includes Provider Relief Fund (PRF) grants reported in Period 5 submission to the PRF Reporting Portal.
Title: 3 (e) Disaster Grants – Public Assistance (ALN 97.036) Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (Schedule) presents the activity of federal award programs administered by Kaleida is in accordance with the requirements of Title 2 U.S. Code of Federal Regulation: Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a select portion of the operations of the Kaleida, it is not intended to and does not present the financial position, changes in net assets, or cash flows of Kaleida. The Schedule is presented on the accrual basis of accounting, except Provide Relief Funds (note 3(e)). The amounts reported as federal expenditures were obtained from Kaleida’s general ledger which is the source of Kaleida’s consolidated financial statements. The general ledger is reconciled to the appropriate federal financial reports for the applicable program and periods. The amounts reported in these federal financial reports are prepared from records maintained for each program. De Minimis Rate Used: N Rate Explanation: Kaleida Health has elected not to charge the 10% de minimis indirect cost rate. Kaleida received funds from Federal Emergency Management Agency (FEMA) to support relief of related expenses attributable to COVID-19. The Schedule includes funds that were obligated by FEMA in 2023 which represents a reimbursement of expenses related to COVID-19 and a significant snow storm that impacted Western New York in 2022.